Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.22.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Warrant [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Jul. 31, 2020 $ 2,305 $ 214,789,808 $ 5,708,127 $ (19,504) $ (206,610,300) $ 13,870,436
Balance, shares at Jul. 31, 2020 23,054,474   3,114,288      
Stock-based compensation expense $ 2 3,213,748 3,213,750
Stock-based compensation expense, shares 19,623          
Tax withholdings paid on equity awards (53,438) (53,438)
Tax shares sold to pay for tax withholdings on equity awards 54,191 54,191
Other comprehensive income (loss) (336,310) (336,310)
Net loss (33,371,690) (33,371,690)
Common stock issued for services $ 10 339,990 340,000
Common stock issued for services, shares 100,000          
Exercise of common stock options $ 30 489,550 489,580
Exercise of common stock options, shares 294,884          
Common stock issued for employee stock purchase plan 5,798 5,798
Common stock issued for employee stock purchase plan, shares 1,538          
Exercise of common stock warrants $ 139 6,580,106 $ (1,787,294) 4,792,951
Exercise of common stock warrants, shares 1,389,261   (1,389,261)      
Purchase of shares under CGP and Sirtex stock purchase agreements $ 169 5,836,562 5,836,731
Purchase of shares under CGP and Sirtex stock purchase agreements, shares 1,691,806          
Dividends declared ($0.00 per share)
Cancellation of expired warrants 242,143 $ (242,143)
Cancellation of expired warrants, shares     (10,712)      
August 2020 Registered Direct Offering, net of $1,464,276 issuance costs $ 461 13,513,177 13,513,638
August 2020 Registered Direct Offering, net of $1,464,276 issuance costs, shares 4,608,589          
January 2021 Public Offering, net of $2,970,165 issuance costs $ 771 39,055,561 39,056,332
January 2021 Public Offering, net of $2,970,165 issuance costs, shares 7,711,284          
Ending balance, value at Apr. 30, 2021 $ 3,887 284,067,196 $ 3,678,690 (355,814) (239,981,990) 47,411,969
Ending balance, shares at Apr. 30, 2021 38,871,459   1,714,315      
Beginning balance, value at Jan. 31, 2021 $ 3,649 274,633,208 $ 4,330,949 (285,323) (230,539,664) 48,142,819
Balance, shares at Jan. 31, 2021 36,491,976   2,221,315      
Stock-based compensation expense $ 1 841,569 841,570
Stock-based compensation expense, shares 6,541          
Tax withholdings paid on equity awards (26,979) (26,979)
Tax shares sold to pay for tax withholdings on equity awards 26,142 26,142
Other comprehensive income (loss) (70,491) (70,491)
Net loss (9,442,326) (9,442,326)
Common stock issued for services $ 4 127,496 127,500
Common stock issued for services, shares 37,500          
Exercise of common stock options $ 13 227,840 227,853
Exercise of common stock options, shares 136,636          
Exercise of common stock warrants $ 51 2,401,358 $ (652,259) 1,749,150
Exercise of common stock warrants, shares 507,000   (507,000)      
Purchase of shares under CGP and Sirtex stock purchase agreements $ 169 5,836,562 5,836,731
Purchase of shares under CGP and Sirtex stock purchase agreements, shares 1,691,806          
Dividends declared ($0.00 per share)
Ending balance, value at Apr. 30, 2021 $ 3,887 284,067,196 $ 3,678,690 (355,814) (239,981,990) 47,411,969
Ending balance, shares at Apr. 30, 2021 38,871,459   1,714,315      
Beginning balance, value at Jul. 31, 2021 $ 3,916 286,337,291 $ 3,591,734 (79,109) (251,778,031) 38,075,801
Balance, shares at Jul. 31, 2021 39,152,610   1,706,190      
Stock-based compensation expense $ 7 1,272,266 1,272,273
Stock-based compensation expense, shares 67,839          
Tax withholdings paid on equity awards (43,383) (43,383)
Tax shares sold to pay for tax withholdings on equity awards 42,949 42,949
Other comprehensive income (loss) 257,840 257,840
Net loss (25,963,350) (25,963,350)
Common stock issued for services $ 1 42,499 42,500
Common stock issued for services, shares 12,500          
Exercise of common stock options $ 13 202,787 202,800
Exercise of common stock options, shares 130,000          
Common stock issued for employee stock purchase plan 1,185 1,185
Common stock issued for employee stock purchase plan, shares 1,500          
Purchase of shares under CGP and Sirtex stock purchase agreements          
Ending balance, value at Apr. 30, 2022 $ 3,937 287,855,594 $ 3,591,734 178,731 (277,741,381) 13,888,615
Ending balance, shares at Apr. 30, 2022 39,364,449   1,706,190      
Beginning balance, value at Jan. 31, 2022 $ 3,935 287,539,711 $ 3,591,734 173,874 (271,494,076) 19,815,178
Balance, shares at Jan. 31, 2022 39,349,269   1,706,190      
Stock-based compensation expense $ 2 315,697 315,699
Stock-based compensation expense, shares 15,180          
Tax withholdings paid on equity awards (10,378) (10,378)
Tax shares sold to pay for tax withholdings on equity awards 10,564 10,564
Other comprehensive income (loss) 4,857 4,857
Net loss (6,247,305) (6,247,305)
Ending balance, value at Apr. 30, 2022 $ 3,937 $ 287,855,594 $ 3,591,734 $ 178,731 $ (277,741,381) $ 13,888,615
Ending balance, shares at Apr. 30, 2022 39,364,449   1,706,190